申请人:CHEMOCENTRYX, INC.
公开号:US10759807B2
公开(公告)日:2020-09-01
The present disclosure provides, inter alia, Compounds of Formula (I)
or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.
本公开特别提供了式 (I) 化合物
或其药学上可接受的盐,它们是 C5a 受体的调节剂。此外,还提供了药物组合物和使用方法,包括治疗涉及 C5a 病理激活的疾病或失调以及非药物应用。